Latest

Talent Is Everywhere. Opportunity Is Not. Why Cognigence Funds Entrepreneurial Education for Girls and Women

Talent Is Everywhere. Opportunity Is Not. Why Cognigence Funds Entrepreneurial Education for Girls and Women

Abstract Talent is everywhere, but opportunity remains deeply unequal. This article examines the persistent barriers keeping millions of girls and women from education and economic independence, from exclusion from upper-secondary education and early marriage to limited financial literacy, restricted access to credit, and unequal entrepreneurial opportunities. Drawing on global

By Team Cognigence
The Compounding Gift: Why Cognigence Invests in Education as the Highest-Leverage Path Out of Poverty

The Compounding Gift: Why Cognigence Invests in Education as the Highest-Leverage Path Out of Poverty

Abstract Poverty relief can address an immediate need, but lasting poverty reduction requires interventions that change what happens next. This article examines why education, particularly entrepreneurial education combined with financial literacy and access to capital, can generate stronger long-term social returns than short-term assistance alone. Drawing on global

By Team Cognigence
Spotlight: Symbio - The AI Platform Giving First Responders the Information They Need to Save Lives

Spotlight: Symbio - The AI Platform Giving First Responders the Information They Need to Save Lives

Abstract Prehospital care is one of the most information-starved environments in healthcare, where paramedics and emergency teams often make critical decisions without access to complete patient histories, encounter records, behavioral health information, or real-time hospital capacity. This article examines how fragmented communication between first responders, hospitals, and community

By Team Cognigence
Why Cognigence Chose to Invest in Cancer Research: The Case for Funding the Gaps Big Pharma Won't Touch

Why Cognigence Chose to Invest in Cancer Research: The Case for Funding the Gaps Big Pharma Won't Touch

Abstract Despite unprecedented advances in oncology, large segments of cancer research remain critically underfunded because pharmaceutical investment is concentrated primarily on commercially profitable cancer types and treatments. This article examines the structural gaps within modern cancer funding, including the neglect of rare cancers, prevention research, early-detection technologies and underserved

By Team Cognigence